A media briefing with experts from the Infectious Diseases Society of America to discuss coronavirus and COVID-19 developments and answer questions.
Topical Agenda for May 1 Briefing:
IDSA will discuss the status of COVID-19 vaccines:
What is the current state of vaccine development?
What are the tradeoffs in accelerating the development of a COVID-19 vaccine?
When a COVID-19 vaccine is approved, what next? What decisions need to be made about the pace of manufacturing and who gets vaccinated first?
Questions from media
FEATURING:
Kathryn M. Edwards, MD, FIDSA — Nashville, TN
Fellow, Infectious Diseases Society of America
Professor of Pediatrics
Sarah H. Sell and Cornelius Vanderbilt Chair
Scientific Director, Vanderbilt Vaccine Research Program
Walter A. Orenstein, MD, FIDSA, FPIDS — Atlanta, GA
Fellow, Infectious Diseases Society of America
Professor and Associate Director, Emory Vaccine Center
Professor, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine
Director, Emory-UGA Center of Excellence for Influenza Research and Surveillance (CEIRS)
Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America
